Collab HIV Collaboration Network Trademark Application
Summary
The USPTO has received an intent-to-use trademark application for 'COLLAB HIV COLLABORATION NETWORK' filed on November 12, 2025. The application covers various educational and informational services related to pharmaceuticals, clinical trials, health, and wellness.
What changed
The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application (TM99493020) for the mark 'COLLAB HIV COLLABORATION NETWORK'. The application, filed on November 12, 2025, seeks to cover a broad range of educational and informational services. These include conducting seminars, workshops, and lectures in the fields of pharmaceuticals, clinical trials, health, and health awareness, as well as providing online instruction and medical information.
This filing indicates a potential future commercial use of the mark in connection with these services. While this is not a regulatory rule or enforcement action, it is a notification of a new trademark application that may impact entities operating in the pharmaceutical, clinical trial, and health information sectors. Compliance officers should be aware of this filing as it pertains to branding and service offerings within the healthcare and pharmaceutical industries.
Archived snapshot
Mar 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
← USPTO Trademark Applications
COLLAB HIV COLLABORATION NETWORK
Intent to Use TM99493020 Kind: intenttouse Mar 22, 2026
Abstract
Educational services, namely, conducting seminars, workshops, lectures and panel discussions in the field of pharmaceuticals, clinical trials, health and health awareness and dissemination of materials in connection therewith; Educational services, namely, providing online instruction in the field of pharmaceuticals, clinical trials, health, and health awareness via an online website; Arranging and conducting of training seminars in the field of pharmaceuticals and clinical trials.; Providing medical information, consultancy and advisory services; Providing healthcare information; Providing medical information; Providing health information; Providing information about health, wellness and nutrition via a website; Providing information in the fields of health and wellness; Providing information, news and commentary in the field of nutrition, health and wellness; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information; Providing scientific information, news, and commentary in the field of pharmaceuticals, clinical trials, nutrition, health and wellness.
Filing Date
2025-11-12
Related changes
Get daily alerts for USPTO Trademarks - Medical Services (Class 044)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Trademarks - Medical Services (Class 044) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.